Dyskeratosis congenita: delay in diagnosis and successful treatment of pancytopenia by bone marrow transplantation
- 1 September 1992
- journal article
- case report
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 127 (3) , 278-280
- https://doi.org/10.1111/j.1365-2133.1992.tb00128.x
Abstract
Summary Dyskeratosis congenita is an inherited disorder characterized by nail dystrophy, skin pigmentary changes, mucosal leukoplakia, pancytopenia and an increased incidence of malignancy. Because of a widely held view that the outcome of bone marrow transplantation in dyskeratosis congenita is poor, this treatment option is sometimes not considered when pancytopenia develops. We present a child currently doing well 3 years after bone marrow transplantation, and review the literature.Keywords
This publication has 9 references indexed in Scilit:
- Case Reports LATE VASCULAR COMPLICATIONS AFTER BONE MARROW TRANSPLANTATION FOR DYSKERATOSIS CONGENITABritish Journal of Haematology, 1991
- Delayed renal failure with extensive mesangiolysis following bone marrow transplantationKidney International, 1989
- Dyskeratosis congenita.Journal of Medical Genetics, 1988
- Intravascular hemolysis and renal insufficiency after bone marrow transplantationBlood, 1988
- Bone Marrow Transplantation for Aplastic Anemia Associated with Dyskeratosis CongenitaJournal of Pediatric Hematology/Oncology, 1988
- Fanconi anemia, dyskeratosis congenita, and WT syndromeAmerican Journal of Medical Genetics, 1987
- Dyskeratosis congenita in a girl simulating chronic graft-vs-host diseaseArchives of Dermatology, 1985
- Marrow transplantation for pancytopenia in dyskeratosis congenitaAnnals of Hematology, 1985
- Dyskeratosis congenita: An autosomal dominant disorderJournal of the American Academy of Dermatology, 1982